Cannabis Law Report

AUGUST 19, 2021

Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. Through the introduction of new cultivars, Cantourage and Cannim are providing new treatment options for patients in Europe. Cantourage continues to provide innovative cultivars and a safe, diverse supply for patients”.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

MMJ Recs

AUGUST 25, 2021

Dispensaries have opened up for business all across the state, but which Pennsylvania dispensaries are leading the pack and bringing patients the best service in 2021? Image by StayRegular on Pixabay : What do Pennsylvania dispensaries sell in 2021? How Do You Get A Pennsylvania MMJ Card In 2021? PA Dispensary Prices.

Dispensary 52

Dispensary Conditions Patients Education 52

TheAnswerPage

JUNE 12, 2021

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. link] accessed Mar 31, 2021. off label)? GW Pharmaceuticals website.

Pharmaceutical 52

Pharmaceutical Access Treatment CBD 52

Cannabis Law Report

JUNE 14, 2022

Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD. However, there is a growing realization that European health systems may not be prepared for these treatments. Psychedelic compounds – such as psilocybin and MDMA – are one such extremely promising area.

Access 52

Access Therapy Clinical Trials Treatment 52

CannaMD

APRIL 20, 2021

More details: Offer valid for orders placed on April 20, 2021. Green Dragon is offering the following deals (valid from 4/14/2021 until 4/24/2021): Select flower ½ oz @ $35 and 1 oz @ $60. Harvest is offering the following deals: Receive a limited edition, 420 Public Access sticker and magnet with any medical purchase.

Safety 105

Safety Marijuana Policy Dispensary 105

Cannabis Law Report

JUNE 29, 2021

“While other states are busy implementing sophisticated medical cannabis programs and tackling the country’s opioid epidemic, more than 1 million Texans continue to misuse prescription pain relievers because they are prohibited from accessing effective alternatives. It’s a very real and devastating public health issue. About Nucleus One.

Treatment 75

Treatment Cultivation Chronic Pain Programs 75

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. 30 September 2021. On 5 August 2021, the TGA announced that an Independent Expert Panel had been established to undertake the review. Summary of the Panel Report. Terms of Reference.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

Cannabis Law Report

AUGUST 10, 2021

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021. With these injustices, and many more, it is clear why many BIPOC might be disinterested in participating in such studies today.

Clinical Trials 105

Clinical Trials Research and Development Therapy Treatment 105

MMJ Recs

AUGUST 20, 2021

The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. In May 2021, however, changes were made by the Drug Enforcement Administration that would allow for other American companies to produce cannabis for research purposes. The roadblocks ahead.

Access 52

Access Research and Development Marijuana Chronic Pain 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. For more than a year, the Department of Health has fought to keep that information secret.

Data 52

Data Treatment Patients Chronic Pain 52

WeedAdvisor

MARCH 19, 2019

The study, which began in 2016 and is set to conclude in 2021, began by assessing the therapeutic effects of CBD in animals with brain injuries. Researchers found that complementary CBD therapy in conjunction with conventional treatment yielded better results. Currently No Medication for Concussions. . Holtz, who holds a Ph.D

Treatment 53

Treatment CBD Research and Development Therapy 53

Cannabis Law Report

JULY 29, 2021

VANCOUVER, BC, July 29, 2021 /CNW/ – Levitee Labs Inc. These assets include 5 addiction treatment clinics across the province of Alberta that have conducted over 35,000 patient visits during the past 12 months. In consideration for the acquisition, Levitee paid $350,000 in cash on the closing date.

Chronic Pain 105

Chronic Pain Treatment Therapy Patients 105

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 105

Business Research and Development Environment Food 105

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. One of our main goals is to increase the accessibility and affordability of medical cannabis as a treatment.”

Patients 84

Patients Treatment Environment Conditions 84

MMJ Recs

MAY 30, 2021

And how much does it cost to get an MMJ card in California in 2021? How Do You Get A Medical Card In California In 2021? How Much Does It Cost To Get A Medical Card In California In 2021? A California medical marijuana card costs $50 in 2021. Do You Still Need A Medical Card In California In 2021?

Dispensary 52

Dispensary Recreational Tincture Chronic Pain 52

TheAnswerPage

AUGUST 17, 2021

Epidiolex is an FDA-approved oral CBD solution indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in one year of age and older. link] Accessed April 30, 2020. Can it be prescribed for indications other than these three seizure disorders (i.e.

Pharmaceutical 52

Pharmaceutical Treatment Access CBD 52

Canna Law Blog

JUNE 20, 2022

Back in March 2021, in Cannabis for Brazilian Pets and Their Humans , we noted that Brazilian courts were granting habeas corpus petitions made by citizens seeking to grow their own cannabis for medical purposes, adding that it would be interesting to see if the trend resulted in judicial decisions of broader application.

Cultivation 98

Cultivation Pets Treatment Decriminalization 98

TheAnswerPage

AUGUST 15, 2021

The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

Cannabis Law Report

MARCH 31, 2022

Planet 13 Announces Q4 and Full Year 2021 Financial Results. Q4 2021 revenue of $29.9 Q4 2021 net loss of $5.1 Q4 2021 Adjusted EBITDA [1] of $1.9 Full year 2021 revenue of $119.5 Full year 2021 net loss of $19.5 Full year 2021 net loss of $19.5 Full year 2021 Adjusted EBITDA of $16.9

Dispensary 52

Dispensary Cultivation Events Business 52

Veriheal

MAY 31, 2022

1, 2020, and July 31, 2021—a 43% increase from the same period a year before. opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions.

Programs 52

Programs Chronic Pain Treatment Conditions 52

TheAnswerPage

JUNE 10, 2021

The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

Cannabis Law Report

DECEMBER 1, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. Date: December 2, 2021. Dates: December 8-9, 2021. Format: 1-on-1 meetings (virtual).

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The post France Wants to Experiment With Giving Away Free Medical Cannabis in 2021 appeared first on Cannabis Central.

Chronic Pain 77

Chronic Pain Pharmaceutical Patients Epilepsy 77

Veriheal

JANUARY 15, 2024

The 2023 World Drug Report shows unreasonable use of criminal penalties for the “war on drugs” movement as it discourages people who use drugs for treatment, and this encourages social stigma. They do not have access to appropriate representation to aid them. The war on drugs also affects certain marginalized groups in society.

Policy 117

Policy Research and Development Collective Law 117

Cannabis Law Report

JANUARY 20, 2022

Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient. Footnotes. Footnotes.

Access 52

Access Programs Treatment Therapy 52

Cannabis Law Report

NOVEMBER 30, 2021

Increases Guidance for Full Year 2021 Revenue to $19.0 TORONTO & SEATTLE–(BUSINESS WIRE)–POSaBIT Systems Corporation (CSE:PBIT, OTC:POSAF), the leading provider of payments infrastructure in the cannabis industry, today announced its financial results for the three months ended September 30, 2021. Million, up 173%.

Business 52

Business Environment Conditions Events 52

Veriheal

DECEMBER 4, 2023

Let’s take a look at how businesses are parting ways with traditional “cannabis tests” as well as how legal access leads to fair employment opportunities for consumers alike. According to 2021 research from the National Institutes of Health (NIH) , 18.7% of individuals aged 12 or older, approximately 52.5

Policy 117

Policy Safety Treatment Business 117

Cannabis Law Report

JUNE 20, 2021

On June 18, 2021, Palo Santo , the leading psychedelic investment fund helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions, issued the following statement regarding atai Life Sciences’ (“atai” or “Company”) ( NASDAQ: ATAI ) initial public offering. .

Research and Development 98

Research and Development Therapy Treatment Access 98

MedicalJane

OCTOBER 28, 2022

billion in 2021. electric vehicle market, which is expected to exhibit substantial growth during the same forecast period (2021-2028), has an estimated CAGR of 25.4% A new report published by The Insight Partners shows that the global medical marijuana market is expected to grow at a CAGR of 19.2%

Chronic Pain 86

Chronic Pain Marijuana Medicine Pharmaceutical 86

Cannabis Law Report

FEBRUARY 17, 2022

Peru represented 5% of the total Latin America unit sales in 2021. In the second half of 2021, the Company opened its first Zerenia™ clinic in Lima , in partnership with Clínica Montesur. Since opening the clinic, over 80% of the consults resulted in cannabis prescriptions.

Patients 52

Patients Treatment Access Collective 52

The Cannigma

JULY 12, 2022

Alabama law does not allow the consumption, possession, or cultivation of marijuana for recreational purposes, but has approved the establishment of a medical marijuana program in February 2021. The same bill was introduced in 2021 but failed in the Senate Chamber. How do people in Alabama view marijuana? CBD regulations.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Canna Law Blog

DECEMBER 16, 2021

On Monday, November 13, 2021, New York Assemblyman Pat Burke introduced medical psilocybin legislation. Qualifying medical practitioners would need to take a two-hour training course provided by the Department of Health in order to certify patients for psilocybin treatment. Rules and Restrictions.

Legislation 96

Legislation Treatment Therapy Conditions 96